It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...

Karen Andersen, CFA, is a healthcare strategist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She is r ...

Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Real-time index price for Nasdaq Industrial Index (INDS), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

US stocks moved higher on Thursday after President Donald Trump said he plans to introduce reciprocal tariffs but delayed ...

Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Laufey Last week Weeks at no. 1 Weeks on chart Laufey/AWAL Week of February 8, 2025 click to see more Laufey/AWAL Epic/Legacy ...